These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6540561)

  • 1. Effect of apomorphine on retention of a brightness discrimination in dopamine supersensitive rats.
    Honza R; Schumacher H; Klauck A; Grecksch G; Matthies H
    Behav Neural Biol; 1984 May; 41(1):23-9. PubMed ID: 6540561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of intrahippocampally applied anisomycin on the retention of brightness discrimination in rats.
    Grecksch G; Ott T; Matthies H
    Behav Neural Biol; 1980 Jul; 29(3):281-8. PubMed ID: 7417193
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of substance P on the retention of a brightness discrimination task in rats.
    Wetzel W; Matthies H
    Acta Biol Med Ger; 1982; 41(7-8):647-52. PubMed ID: 6183854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of dopaminergic mechanisms in the rat hippocampus for the consolidation in a brightness discrimination.
    Grecksch G; Matties H
    Psychopharmacology (Berl); 1981; 75(2):165-8. PubMed ID: 6798605
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.
    Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
    Eur J Pharmacol; 1982 Jun; 81(1):1-9. PubMed ID: 6889533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic analysis of central nervous system supersensitivity induced in rats by long-term haloperidol administration. I. pA2 determination.
    Palermo-Neto J; Bernardi MM; Saban R
    Pharmacology; 1984; 28(4):203-10. PubMed ID: 6539476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intraventricularly applied gangliosides and N-acetylneuraminic acid on acquisition and retention performance of a brightness discrimination task in rats.
    Popov N; Toffano G; Riechert U; Matthies H
    Pharmacol Biochem Behav; 1989 Oct; 34(2):209-12. PubMed ID: 2622976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participation of angiotensin II in learning and memory. II. Interactions of angiotensin II with dopaminergic drugs.
    Yonkov DI; Georgiev VP; Opitz MJ
    Methods Find Exp Clin Pharmacol; 1986 Apr; 8(4):203-6. PubMed ID: 3724295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haloperidol-induced supersensitivity to the discrimination of apomorphine.
    Schechter MD
    Eur J Pharmacol; 1981 Sep; 74(4):343-6. PubMed ID: 7297600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of apomorphine and haloperidol on memory consolidation in the day-old chick.
    Hale MW; Crowe SF
    Behav Neurosci; 2001 Apr; 115(2):376-83. PubMed ID: 11345962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the potential neuroleptic peptide des-tyrosine-gamma-endorphin and haloperidol on apomorphine-induced behavioural syndromes in rats and mice.
    Nickolson VJ; Berendsen HH
    Life Sci; 1980 Oct; 27(15):1377-85. PubMed ID: 7192353
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
    Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scopolamine deficits in negative patterning discrimination: evidence for a role of the central cholinergic system in retention but not acquisition of non-spatial configural association learning.
    Moran PM
    Behav Brain Res; 1992 Jun; 48(2):187-97. PubMed ID: 1616609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apomorphine as a discriminative stimulus, and its antagonism by haloperidol.
    Colpaert FC; Niemegeers CJ; Kuyps JJ; Janssen PA
    Eur J Pharmacol; 1975; 32(02):383-6. PubMed ID: 1149818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiological and behavioral assessments of dopamine autoreceptor activation to apomorphine in rats.
    Okuyama S; Shimamura H; Hashimoto S; Aihara H
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):246-54. PubMed ID: 3827410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subchronic treatment with haloperidol and clozapine in rats with neonatal excitotoxic hippocampal damage.
    Lipska BK; Weinberger DR
    Neuropsychopharmacology; 1994 May; 10(3):199-205. PubMed ID: 7916917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of apomorphine and haloperidol on "spontaneous" stereotyped licking behaviour in the Cebus monkey.
    Korsgaard S; Povlsen UJ; Randrup A
    Psychopharmacology (Berl); 1985; 85(2):240-3. PubMed ID: 3925490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haloperidol, but not apomorphine, differentially affects low response rates of male and female Wistar rats.
    Van Hest A; van Haaren F; van de Poll NE
    Pharmacol Biochem Behav; 1988 Mar; 29(3):529-32. PubMed ID: 3362947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative learning occasioned by the administration of a dopamine agonist.
    Keller S; Delius JD
    Psychopharmacology (Berl); 2001 Sep; 157(3):320-3. PubMed ID: 11605089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of amantadine HCl on haloperidol-induced striatal dopamine neuron hypersensitivity.
    Allen RM; Flemenbaum A
    Biol Psychiatry; 1979 Jun; 14(3):541-4. PubMed ID: 573144
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.